Clinical Roundup Adjuvant everolimus may improve RFS in high-risk kidney cancer June 03, 2022Vol.48 No.22
Clinical Roundup Allocetra + PD-1 checkpoint inhibition shows survival benefit in ovarian cancer June 03, 2022Vol.48 No.22
Clinical Roundup CLN-081 demonstrates positive potential in EGFR exon 20 insertion mutation positive NSCLC June 03, 2022Vol.48 No.22
Clinical Roundup Sugemalimab, aumolertinib show clinical benefit in NSCLC, r/r ENKTL June 03, 2022Vol.48 No.22
Clinical Roundup Genetic testing changes cancer treatment plans, Invitae studies suggest June 03, 2022Vol.48 No.22
Clinical Roundup CPI-613 may be used to treat clear cell sarcoma, pancreatic, biliary tract cancer June 03, 2022Vol.48 No.22
Clinical Roundup Lasofoxifene + abemaciclib shows potential in ER+/HER2− breast cancer with ESR1 mutation June 03, 2022Vol.48 No.22
Clinical Roundup SWOG researchers use cell-free DNA methylation to predict chemo benefit in bladder cancer May 27, 2022Vol.48 No.21
Clinical Roundup Roswell Park study: Targeting the E3 ligase activity of MDM2 could help control p53 protein May 27, 2022Vol.48 No.21
